197 related articles for article (PubMed ID: 35133881)
1. Noncoding RNAs Interplay in Ovarian Cancer Therapy and Drug Resistance.
Liu M; Zhang H; Li Y; Wang S
Cancer Biother Radiopharm; 2022 Apr; 37(3):186-198. PubMed ID: 35133881
[TBL] [Abstract][Full Text] [Related]
2. Role of autophagy and its regulation by noncoding RNAs in ovarian cancer.
Feng C; Yuan X
Exp Biol Med (Maywood); 2023 Jun; 248(12):1001-1012. PubMed ID: 36803116
[TBL] [Abstract][Full Text] [Related]
3. HER2 puzzle pieces: Non-Coding RNAs as keys to mechanisms, chemoresistance, and clinical outcomes in Ovarian cancer.
Yang F; Yan L; Ji J; Lou Y; Zhu J
Pathol Res Pract; 2024 Jun; 258():155335. PubMed ID: 38723327
[TBL] [Abstract][Full Text] [Related]
4. Noncoding RNA (ncRNA) Profile Association with Patient Outcome in Epithelial Ovarian Cancer Cases.
Oliveira DVNP; Prahm KP; Christensen IJ; Hansen A; Høgdall CK; Høgdall EV
Reprod Sci; 2021 Mar; 28(3):757-765. PubMed ID: 33125686
[TBL] [Abstract][Full Text] [Related]
5. Noncoding RNAs in cancer and cancer stem cells.
Huang T; Alvarez A; Hu B; Cheng SY
Chin J Cancer; 2013 Nov; 32(11):582-93. PubMed ID: 24206916
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA WDFY3-AS2 suppresses tumor progression by acting as a competing endogenous RNA of microRNA-18a in ovarian cancer.
Li W; Ma S; Bai X; Pan W; Ai L; Tan W
J Cell Physiol; 2020 Feb; 235(2):1141-1154. PubMed ID: 31347170
[TBL] [Abstract][Full Text] [Related]
7. Long Noncoding RNA LINC01125 Enhances Cisplatin Sensitivity of Ovarian Cancer via miR-1972.
Guo J; Pan H
Med Sci Monit; 2019 Dec; 25():9844-9854. PubMed ID: 31865363
[TBL] [Abstract][Full Text] [Related]
8. Silencing of lncRNA DLEU1 inhibits tumorigenesis of ovarian cancer via regulating miR-429/TFAP2A axis.
Xu H; Wang L; Jiang X
Mol Cell Biochem; 2021 Feb; 476(2):1051-1061. PubMed ID: 33170430
[TBL] [Abstract][Full Text] [Related]
9. miRNAs and ovarian cancer: An overview.
Deb B; Uddin A; Chakraborty S
J Cell Physiol; 2018 May; 233(5):3846-3854. PubMed ID: 28703277
[TBL] [Abstract][Full Text] [Related]
10. Re: "Noncoding RNAs Interplay in Ovarian Cancer Therapy and Drug Resistance" by Liu et al.
Özdemir BG
Cancer Biother Radiopharm; 2024 Feb; 39(1):102. PubMed ID: 38109222
[No Abstract] [Full Text] [Related]
11. Long non-coding RNA GAS5 inhibits DDP-resistance and tumor progression of epithelial ovarian cancer via GAS5-E2F4-PARP1-MAPK axis.
Long X; Song K; Hu H; Tian Q; Wang W; Dong Q; Yin X; Di W
J Exp Clin Cancer Res; 2019 Aug; 38(1):345. PubMed ID: 31391118
[TBL] [Abstract][Full Text] [Related]
12. Noncoding RNAs in oral cancer.
Balakittnen J; Weeramange CE; Wallace DF; Duijf PHG; Cristino AS; Kenny L; Vasani S; Punyadeera C
Wiley Interdiscip Rev RNA; 2023; 14(3):e1754. PubMed ID: 35959932
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA ATB promotes ovarian cancer tumorigenesis by mediating histone H3 lysine 27 trimethylation through binding to EZH2.
Chen XJ; An N
J Cell Mol Med; 2021 Jan; 25(1):37-46. PubMed ID: 33336896
[TBL] [Abstract][Full Text] [Related]
14. NCALD affects drug resistance and prognosis by acting as a ceRNA of CX3CL1 in ovarian cancer.
Dong C; Yin F; Zhu D; Cai X; Chen C; Liu X
J Cell Biochem; 2020 Nov; 121(11):4470-4483. PubMed ID: 32030795
[TBL] [Abstract][Full Text] [Related]
15. NCK1-AS1 promotes NCK1 expression to facilitate tumorigenesis and chemo-resistance in ovarian cancer.
Chang H; Li B; Zhang X; Meng X
Biochem Biophys Res Commun; 2020 Feb; 522(2):292-299. PubMed ID: 31761329
[TBL] [Abstract][Full Text] [Related]
16. The pivotal role of long non-coding RNAs as potential biomarkers and modulators of chemoresistance in ovarian cancer (OC).
Malgundkar SH; Tamimi Y
Hum Genet; 2024 Feb; 143(2):107-124. PubMed ID: 38276976
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of long non‑coding RNA CCEPR is associated with poor prognosis and contributes to the progression of ovarian cancer through regulating the Wnt/β‑catenin signaling pathway.
Chen Z; Zhu Y; Fan X; Liu Y; Feng Q
Mol Med Rep; 2020 Apr; 21(4):1950-1958. PubMed ID: 32319633
[TBL] [Abstract][Full Text] [Related]
18. Long Noncoding RNA SCAMP1 Targets miR-137/CXCL12 Axis to Boost Cell Invasion and Angiogenesis in Ovarian Cancer.
Song R; Liu Z; Lu L; Liu F; Zhang B
DNA Cell Biol; 2020 Jun; 39(6):1041-1050. PubMed ID: 32401536
[TBL] [Abstract][Full Text] [Related]
19. The role of miRNAs in ovarian cancer pathogenesis and therapeutic resistance - A focus on signaling pathways interplay.
Ismail A; Abulsoud AI; Fathi D; Elshafei A; El-Mahdy HA; Elsakka EGE; Aglan A; Elkhawaga SY; Doghish AS
Pathol Res Pract; 2022 Dec; 240():154222. PubMed ID: 36413828
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance and oncogene function of long noncoding RNA HAGLROS overexpression in ovarian cancer.
Yang M; Zhai Z; Zhang Y; Wang Y
Arch Gynecol Obstet; 2019 Sep; 300(3):703-710. PubMed ID: 31197441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
